|
Description
Multi-format, multiplexing xMAP technology is the smart choice for research or diagnostic applications regarding metabolic markers — whether genetic or protein-based. The technology is particularly ideal for clinical diagnostic use, as it allows for multi-analyte profiles with the ability to build internal controls into the various assays. Luminex's breakthrough approach offers comparable sensitivity to traditional ELISA-based systems, but with additional advantages including multiplexing, extended dynamic range, smaller sample size, and dramatically reduced workload.
Tests available from:
EMD/Merck (Novagen)
Millipore Corporation (LINCO & Upstate)
Rules Based Medicine
|